Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Rates of COVID-19-related Outcomes in Cancer compared to non-Cancer Patients

Lova Sun, Sanjna Surya, Anh N. Le, Heena Desai, Abigail Doucette, Peter Gabriel, Marylyn Ritchie, Daniel Rader, Ivan Maillard, Erin Bange, Alexander Huang, Robert H. Vonderheide, Angela DeMichele, Anurag Verma, Ronac Mamtani, Kara N. Maxwell
doi: https://doi.org/10.1101/2020.08.14.20174961
Lova Sun
1Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sanjna Surya
1Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anh N. Le
1Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heena Desai
1Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abigail Doucette
2Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, 19104
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Gabriel
2Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, 19104
4Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, 19104
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marylyn Ritchie
3Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Rader
3Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ivan Maillard
1Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104
4Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, 19104
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erin Bange
1Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Huang
1Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert H. Vonderheide
1Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104
4Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, 19104
MD, DPhil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angela DeMichele
1Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104
4Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, 19104
MD, MSCE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anurag Verma
3Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronac Mamtani
1Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104
4Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, 19104
MD, MSCE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kara N. Maxwell
1Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104
3Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104
4Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, 19104
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kara.maxwell@pennmedicine.upenn.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Cancer patients are a vulnerable population postulated to be at higher risk for severe COVID-19 infection. Increased COVID-19 morbidity and mortality in cancer patients may be attributable to age, comorbidities, smoking, healthcare exposure, and cancer treatments, and partially to the cancer itself. Most studies to date have focused on hospitalized patients with severe COVID-19, thereby limiting the generalizability and interpretability of the association between cancer and COVID-19 severity. We compared outcomes of SARS-CoV-2 infection in 323 patients enrolled prior to the pandemic in a large academic biobank (n=67 cancer patients and n=256 non-cancer patients). After adjusting for demographics, smoking status, and comorbidities, a diagnosis of cancer was independently associated with higher odds of hospitalization (OR 2.16, 95% CI 1.12-4.18) and 30-day mortality (OR 5.67, CI 1.49-21.59). These associations were primarily driven by patients with active cancer. These results emphasize the critical importance of preventing SARS-CoV-2 exposure and mitigating infection in cancer patients.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the National Institutes of Health (P30-CA016520 to Abramson Cancer Center)

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The PMBB is approved under IRB protocol# 813913 and supported by Perelman School of Medicine at University of Pennsylvania.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data that support the findings of this study are available on request and subject to data use agreement. The data are not publicly available due to information that could compromise the privacy of research participants.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted August 16, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Rates of COVID-19-related Outcomes in Cancer compared to non-Cancer Patients
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Rates of COVID-19-related Outcomes in Cancer compared to non-Cancer Patients
Lova Sun, Sanjna Surya, Anh N. Le, Heena Desai, Abigail Doucette, Peter Gabriel, Marylyn Ritchie, Daniel Rader, Ivan Maillard, Erin Bange, Alexander Huang, Robert H. Vonderheide, Angela DeMichele, Anurag Verma, Ronac Mamtani, Kara N. Maxwell
medRxiv 2020.08.14.20174961; doi: https://doi.org/10.1101/2020.08.14.20174961
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Rates of COVID-19-related Outcomes in Cancer compared to non-Cancer Patients
Lova Sun, Sanjna Surya, Anh N. Le, Heena Desai, Abigail Doucette, Peter Gabriel, Marylyn Ritchie, Daniel Rader, Ivan Maillard, Erin Bange, Alexander Huang, Robert H. Vonderheide, Angela DeMichele, Anurag Verma, Ronac Mamtani, Kara N. Maxwell
medRxiv 2020.08.14.20174961; doi: https://doi.org/10.1101/2020.08.14.20174961

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Oncology
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (579)
  • Anesthesia (141)
  • Cardiovascular Medicine (1960)
  • Dentistry and Oral Medicine (253)
  • Dermatology (186)
  • Emergency Medicine (334)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (702)
  • Epidemiology (11120)
  • Forensic Medicine (8)
  • Gastroenterology (629)
  • Genetic and Genomic Medicine (3193)
  • Geriatric Medicine (310)
  • Health Economics (566)
  • Health Informatics (2048)
  • Health Policy (864)
  • Health Systems and Quality Improvement (789)
  • Hematology (310)
  • HIV/AIDS (684)
  • Infectious Diseases (except HIV/AIDS) (12739)
  • Intensive Care and Critical Care Medicine (708)
  • Medical Education (318)
  • Medical Ethics (92)
  • Nephrology (337)
  • Neurology (3000)
  • Nursing (165)
  • Nutrition (465)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1561)
  • Ophthalmology (478)
  • Orthopedics (185)
  • Otolaryngology (266)
  • Pain Medicine (202)
  • Palliative Medicine (57)
  • Pathology (403)
  • Pediatrics (914)
  • Pharmacology and Therapeutics (384)
  • Primary Care Research (355)
  • Psychiatry and Clinical Psychology (2795)
  • Public and Global Health (5610)
  • Radiology and Imaging (1100)
  • Rehabilitation Medicine and Physical Therapy (636)
  • Respiratory Medicine (764)
  • Rheumatology (341)
  • Sexual and Reproductive Health (314)
  • Sports Medicine (289)
  • Surgery (347)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (133)